- $83.81bn
- $101.99bn
- £31.38bn
- 70
- 69
- 83
- 88
REG - GlaxoSmithKline PLC - Second Price Monitoring Extn
AnnouncementREG - GlaxoSmithKline PLC - Price Monitoring Extension
AnnouncementREG - GlaxoSmithKline PLC - Block listing Interim Review
AnnouncementREG - GlaxoSmithKline PLC - Holding(s) in Company
AnnouncementREG - GlaxoSmithKline PLC - ViiV PrEP jab shows high efficacy over daily pill
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSK Capital PLC GlaxoSmithKline PLC - Publication of Final Terms
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK sells its holding in Hindustan Unilever
AnnouncementREG - GlaxoSmithKline PLC - Result of AGM
AnnouncementREG - J.P. Morgan Sec PLC GlaxoSK Capital PLC - Stabilisation Notice
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Publication of a Prospectus
AnnouncementREG - GlaxoSmithKline PLC - Rights attached to ordinary shares
AnnouncementREG - J.P. Morgan Sec PLC GlaxoSK Capital PLC - Stabilisation Notice
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSK Capital PLC - Publication of a Prospectus
AnnouncementREG - GlaxoSmithKline PLC - GSK’s Zejula approved in first-line ovarian cancer
Announcement